'For
the quarter ending June 2024, consolidated Net sales (including other operating income) of Torrent Pharmaceuticals has increased 10.34% to Rs 2859 crore compared to quarter ended June 2023.Operating profit margin has jumped from 30.53% to 31.62%, leading to 14.29% rise in operating profit to Rs 904.00 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 16.57% to 14.23%. Purchase of finished goods cost rose from 9.52% to 10.83%. Employee cost increased from 19.00% to 19.04%. Other expenses fell from 24.79% to 24.61%. Other income fell 29.41% to Rs 24 crore. PBIDT rose 12.48% to Rs 928 crore. Provision for interest fell 27.18% to Rs 75 crore.
PBDT rose 18.14% to Rs 853 crore. Provision for depreciation rose 3.14% to Rs 197 crore.
Profit before tax grew 23.54% to Rs 656.00 crore. Share of pr...
Pleaselogin & subscribe to view the full report.
More Reports
-
(30-Aug-2024)
Gillette India
-
Net down 5% on lower sales
-
Net jump 159% on good operating show
-
Net up 50% on good operating show
|
|